Developing a National Strategy for SARS-CoV-2 Serosurveys in the United States | NLM

Disaster Information Management Research Center | NLM

Developing a National Strategy for SARS-CoV-2 Serosurveys in the United States

06/18/2020 12:00 AM EDT

Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 6/18/2020. This 37-page document describes the value of serosurveys (antibody studies) for SARS-CoV-2 infections, the different methods by which they can be performed, and the resources required to produce actionable information. It provides recommendations for the U.S. government and states for performing these studies and deriving value from them. (PDF)